Literature DB >> 12073024

Investigating the association between OPA1 polymorphisms and glaucoma: comparison between normal tension and high tension primary open angle glaucoma.

Tin Aung1, Louise Ocaka, Neil D Ebenezer, Alex G Morris, Glen Brice, Anne H Child, Roger A Hitchings, Ordan J Lehmann, Shomi S Bhattacharya.   

Abstract

OPA1, the gene responsible for autosomal dominant optic atrophy, represents a good candidate gene for glaucoma, as there are similarities in the clinical phenotype and OPA1 is expressed in the optic nerve. Single nucleotide polymorphisms on intervening sequence (IVS) 8 of the OPA1gene (genotype IVS8+4 C/T;+32T/C) were recently found to be strongly associated with normal tension glaucoma (NTG). In order to investigate whether this association exists in patients with high-tension glaucoma (HTG), 90 well-characterized HTG patients were examined for the presence of these OPA1polymorphisms by PCR amplification followed by bi-directional sequencing. Five out of 90 HTG subjects (5.6%; 95% CI 1.8-12.5) were found to carry the OPA1 genotype IVS 8+4 C/T; +32 T/C, compared with 32/163 (19.6%; 95% CI 13.8-26.6) NTG subjects [chi(2)=9.2, P=0.002, OR 4.1 (95% CI 1.6-11.1)], and 7/186 (3.8%; 95% CI 1.5-7.6) control subjects [chi(2)=0.47, P=0.49, OR 1.5 (95% CI 0.5-4.9)]. These results indicate that unlike NTG, the OPA1 genotype IVS8+4 C/T,+32T/C is not significantly associated with high-tension primary open angle glaucoma, and suggest genetic heterogeneity between the conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12073024     DOI: 10.1007/s00439-002-0711-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  The OPA1 gene and optic neuropathy.

Authors:  W L M Alward
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

2.  Age related retinal Ganglion cell susceptibility in context of autophagy deficiency.

Authors:  Katharina Bell; Ines Rosignol; Elena Sierra-Filardi; Natalia Rodriguez-Muela; Carsten Schmelter; Francesco Cecconi; Franz Grus; Patricia Boya
Journal:  Cell Death Discov       Date:  2020-04-17

3.  Short wavelength-automated perimetry compared with standard achromatic perimetry in autosomal dominant optic atrophy.

Authors:  J W Walters; A Gaume; L Pate
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

4.  The role of the Met98Lys optineurin variant in inherited optic nerve diseases.

Authors:  J E Craig; A W Hewitt; D P Dimasi; N Howell; C Toomes; A C Cohn; D A Mackey
Journal:  Br J Ophthalmol       Date:  2006-08-02       Impact factor: 4.638

Review 5.  A review of primary hereditary optic neuropathies.

Authors:  M Votruba; S Aijaz; A T Moore
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 6.  Recent advances in molecular genetics of glaucoma.

Authors:  Kunal Ray; Arijit Mukhopadhyay; Moulinath Acharya
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

7.  Association of OPA1 polymorphisms with NTG and HTG: a meta-analysis.

Authors:  Yatu Guo; Xia Chen; Hongtuan Zhang; Ningdong Li; Xiong Yang; Wenbo Cheng; Kanxing Zhao
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

8.  Variation in OPA1 does not explain the incomplete penetrance of Leber hereditary optic neuropathy.

Authors:  Gavin Hudson; Patrick Yu-Wai-Man; Phillip G Griffiths; Leonardo Caporali; Solange S Salomao; Adriana Berezovsky; Valerio Carelli; Massimo Zeviani; Patrick F Chinnery
Journal:  Mol Vis       Date:  2010-12-15       Impact factor: 2.367

9.  Investigation of the association between interleukin-1beta polymorphism and normal tension glaucoma.

Authors:  Chun Yuan Wang; Ying-Cheng Shen; Chien-Hui Su; Fai-Yun Lo; Shi-Huang Lee; Hin-Yeung Tsai; Seng-Sheen Fan
Journal:  Mol Vis       Date:  2007-05-14       Impact factor: 2.367

10.  OPA1 increases the risk of normal but not high tension glaucoma.

Authors:  P Yu-Wai-Man; J D Stewart; G Hudson; R M Andrews; P G Griffiths; M K Birch; P F Chinnery
Journal:  J Med Genet       Date:  2009-07-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.